Advertisement
YOU ARE HERE: LAT HomeCollectionsJames Donegan
IN THE NEWS

James Donegan

FEATURED ARTICLES
CALIFORNIA | LOCAL
September 7, 1999
Med-Design Corp. in Ventura, which designs safety needle products for medical use, reported a net loss of $850,000 or 11 cents per share for the three months that ended June 30. This loss was less than the $900,000 or 11 cents per share reported a year ago for the second quarter. James Donegan, chairman and chief executive officer, said changes in various state laws this year will increase the demand for safety needles and improve Med-Design's position in the market.
ARTICLES BY DATE
Advertisement
BUSINESS
February 4, 1997 | BARBARA MURPHY
Med-Design Corp. has successfully completed a private placement of 1 million shares of the company's common stock to help finance its pilot manufacturing facility in Ventura. Net proceeds to Med-Design are approximately $4.67 million, officials with the Philadelphia-based company said. Besides financing the manufacturing facility, the additional equity capital will enable Med-Design to proceed with the final development of its safety needle product line.
CALIFORNIA | LOCAL
November 30, 1999 | BARBARA MURPHY
The Med-Design Corp. in Ventura, which designs safety needle products for medical use, has appointed Michael W. Simpson executive vice president and chief operating officer. Simpson joins Med-Design from Becton Dickinson, where he was worldwide director of Advance Protection Infusion Therapy Systems. While at Becton, Dickinson was responsible for product development, manufacturing and marketing of safety IV catheters and catheter products.
BUSINESS
November 18, 1997 | BARBARA MURPHY
The Med-Design Corp. has received Food and Drug Administration approval to market its MDC Safe Step Blood Collection Needle System. The approval came 85 days after the company filed with the FDA for clearance to market the new blood-collection device. "We are extremely pleased by the prompt attention given by the FDA to our . . . filing," said James Donegan, Med-Design chairman and chief executive officer.
CALIFORNIA | LOCAL
April 13, 1999
The Med-Design Corp. in Ventura, which designs safety needle products for medical use, reported $3.3 million in net income for the fourth quarter of 1998, compared with a loss of $1.9 million in the same period in 1997. Also for the quarter ended Dec. 31, revenue was $4.5 million, which came from the initial payment under the Becton, Dickinson and Co. licensing agreement. The company did not report any revenue in the fourth quarter of 1997. For the full year, Med-Design reported revenue of $4.
CALIFORNIA | LOCAL
February 22, 2000 | BARBARA MURPHY
The Med-Design Corp. in Ventura, which designs safety needle products for medical use, has purchased an early safety syringe patent issued to Dr. Edward Allard in 1989. Earlier, Med-Design purchased a safety syringe patent that had been issued in 1989 to Dr. John Kulli. The Kulli and Allard patents have long been considered significant for safety syringes employing spring-loaded needle retraction.
CALIFORNIA | LOCAL
May 30, 2000 | BARBARA MURPHY
Med-Design Corp. in Ventura, which makes safety needle products for medical use, has signed an agreement giving Becton Dickinson a worldwide exclusive license to utilize Med-Design's patent rights and know-how in the manufacture and sale of safety syringe products. Med-Design will receive an up-front payment of $4 million, $1.5 million of which was recognized in the first quarter, with the remaining $2.5 million to be recognized this quarter.
BUSINESS
March 18, 1988 | From Reuters
Canada's surging currency burst through the (U.S.) 80-cent mark in early trading on North American markets Thursday, reaching its highest level in more than four years. The currency, flirting with the psychologically important level during busy trading Wednesday, finally topped the barrier early in the day and reached 80.08 U.S. cents--its highest level since Feb. 24, 1984--before falling back slightly at midday. The Canadian dollar closed at 79.90 cents Wednesday.
Los Angeles Times Articles
|